JO
XBIT icon

John Overdeck’s XBiotech XBIT Stock Holding History

John Overdeck’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-12,393
Closed -$40.2K – 3584
2025
Q1 		$40.2K Buy
+12,393
New +$42.7K ﹤0.01% 3066
2024
Q2 		– Sell
-10,707
Closed -$87K – 3368
2024
Q1 		$87K Sell
10,707
-14,733
-58% -$84.4K ﹤0.01% 2845
2023
Q4 		$102K Sell
25,440
-5,400
-18% -$21.5K ﹤0.01% 2936
2023
Q3 		$127K Sell
30,840
-14,200
-32% -$71.1K ﹤0.01% 2719
2023
Q2 		$268K Sell
45,040
-9,897
-18% -$44.7K ﹤0.01% 2548
2023
Q1 		$190K Sell
54,937
-11,099
-17% -$41.4K ﹤0.01% 2571
2022
Q4 		$232K Sell
66,036
-11,061
-14% -$37.7K ﹤0.01% 2343
2022
Q3 		$279K Buy
77,097
+14,048
+22% +$66.1K ﹤0.01% 1991
2022
Q2 		$355K Buy
63,049
+51,457
+444% +$346K ﹤0.01% 1959
2022
Q1 		$100K Buy
+11,592
New +$116K ﹤0.01% 2432

Other funds holding XBIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.41B AUM 39.41% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

John Overdeck's XBIT Position: Q2 2025 in Review

John Overdeck sold out of XBiotech (XBIT) in Q2 2025, closing a stake of 12,393 shares — an estimated $40.2K sold.

John Overdeck first reported a position in XBIT in Q1 2022 and held it in 10 quarters. The position peaked at $355K in Q2 2022. 53 funds tracked by Wall St. Rank hold XBIT as of Q2 2025.

  • John Overdeck reported no remaining XBiotech position as of Q2 2025 after selling out during the quarter.
  • John Overdeck sold 12,393 XBiotech shares in Q2 2025, an estimated $40.2K.
  • John Overdeck first reported a position in XBiotech in Q1 2022 and held it in 10 quarters.
  • John Overdeck's XBiotech position peaked at $355K in Q2 2022.
  • 53 funds tracked by Wall St. Rank held XBiotech as of Q2 2025.

Based on Two Sigma Investments's 13F filing for Q2 2025, filed 14 Aug 2025.